Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2025-05-09 Interim / Quarterly Rep…
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
First quarter 2025 financial results and status for Medistim ASA
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Q1 2025 Financial Report' and contains comprehensive financial statements, including income statements, balance sheets, and detailed management analysis of quarterly performance (sales, geographic split, currency effects, and operational status). It covers a period shorter than a full fiscal year (Q1 2025). It is not a mere announcement or certification, but the full interim report itself. Q1 2025
2025-05-09 English
First quarter 2025 financial results and status for Medistim ASA
Earnings Release Classification · 100% confidence The document text explicitly details the "First quarter 2025 financial results and status," highlighting key performance indicators such as sales revenues (MNOK 181.5), operating profit (EBIT), EBIT margin, and cash position. It also mentions the dividend decision made by the General Meeting. This content structure—providing key financial highlights for a specific interim period (first quarter)—is characteristic of an Earnings Release (ER). It is not a comprehensive report (like 10-K or IR) nor is it merely an announcement of a report's publication (RPA). The mention of the dividend decision is secondary to the primary financial results announcement. Q1 2025
2025-05-09 English
The General Meeting in Medistim ASA decided a dividend of NOK 6.00 per share
Notice of Dividend Amount Classification · 99% confidence The document explicitly states that the General Meeting resolved to distribute a dividend of NOK 6.00 per share based on the 2024 financial year results. It details the total amount, the record date (as of May 8th, 2025), the ex-date (May 9th, 2025), and the payment date (May 19th, 2025). This content directly corresponds to the definition of a Notice of Dividend Amount (DIV), which covers the announcement of dividend amounts and payment details.
2025-05-08 English
Protocol from General Meeting in Medistim ASA
AGM Information Classification · 100% confidence The document is explicitly titled "MINUTES FROM THE GENERAL MEETING IN MEDISTIM ASA" and details the proceedings, agenda items, and voting results of a meeting held on May 8th, 2025. Key items discussed include the approval of the annual report, dividend distribution, remuneration policy, election of board members, and authorizations for capital increases and share purchases. This content perfectly matches the definition of materials shared during an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2025-05-08 English
Protocol from General Meeting in Medistim ASA
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document title explicitly states "Results of the voting and participation at the General meeting in Medistim ASA the 8th of May 2025" and includes detailed tables showing the results of various resolutions (e.g., approval of annual report, remuneration policy, election of board members) with votes 'In favour', 'Against', and 'Abstain'. This content directly corresponds to the official results from a shareholder vote at a general meeting. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-05-08 English
Protocol from General Meeting in Medistim ASA
AGM Information Classification · 95% confidence The document text explicitly states it is the 'Protocol from General Meeting in Medistim ASA' and mentions 'votes from the General Meeting'. This directly relates to the proceedings and outcomes of a shareholder meeting. The closest specific category is AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting (AGM). Although it mentions the protocol/votes, which could sometimes fall under DVA, the context of 'Protocol from General Meeting' strongly suggests AGM material.
2025-05-08 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.